×
chevron-orange.svg

Demonstrated Diagnostic Performance

Accuracy Metrics

DecisionDx® DiffDx-Melanoma provides a highly accurate and objective evaluation resulting in a benign or malignant result in >96% of lesions receiving a test result.

0%

Sensitivity
95% CI: 97.9-100

0%

Specificity
95% CI: 91.5-97.1

0%

PPV
95% CI: 90.5-96.7

0%

NPV
95% CI: 98.1-100

0%

Intermediate Risk

Diagnostic Goals in Sharper Resolution

For Dermatopathologists

Create a clinically actionable pathology report in more cases

Inform more appropriate management plans for dermatologists and their patients

Obtain diagnostic confidence: Your patient is receiving a diagnosis aided by objective and dependable gene expression analysis

For Dermatologists

Provide your patient with a more clinically actionable diagnosis

Implement more appropriate patient management plans

Enhance clinical confidence: your patient is receiving the appropriate treatment based on a clinically validated, objective evaluation

Scroll to Top
Scroll to Top